CIPRO HC Drug Patent Profile
✉ Email this page to a colleague
When do Cipro Hc patents expire, and what generic alternatives are available?
Cipro Hc is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in CIPRO HC is ciprofloxacin hydrochloride; hydrocortisone. There are thirty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride; hydrocortisone profile page.
Summary for CIPRO HC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 42 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CIPRO HC |
What excipients (inactive ingredients) are in CIPRO HC? | CIPRO HC excipients list |
DailyMed Link: | CIPRO HC at DailyMed |
Pharmacology for CIPRO HC
Anatomical Therapeutic Chemical (ATC) Classes for CIPRO HC
US Patents and Regulatory Information for CIPRO HC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CIPRO HC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CIPRO HC
See the table below for patents covering CIPRO HC around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 7140587 | ⤷ Try a Trial | |
Spain | 516921 | ⤷ Try a Trial | |
Mexico | 9701731 | COMPOSICIONES ANTI-BACTERIANAS OTICAS, NO-IRRITANTES, NO-SENSIBLES Y NO-TOXICAS PARA EL OIDO. (METHOD AND APPARATUS FOR DETECTING BARRETT'S METAPLASIA OF THE ESOPHAGUS.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CIPRO HC
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | 13C0012 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1429780 | 132013902137451 | Italy | ⤷ Try a Trial | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |